Penny J. Barnes
Halifax, NS, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Toward Accurate Deep Learning-Based Prediction of Ki67, ER, PR, and HER2 Status From H&E-Stained Breast Cancer Images.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: January 08, 2024
Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: November 22, 2023
Metastatic Mammary Carcinoma Presenting as a Large Cystic Axillary Mass: A Report of an Unusual Case.
Journal: International journal of surgical pathology
Published: February 21, 2023
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force.
Journal: Current oncology (Toronto, Ont.)
Published: February 02, 2023
Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by Immunohistochemistry.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: April 05, 2022
HER2 testing in metastatic breast cancer - Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?
Journal: Annals of diagnostic pathology
Published: March 22, 2022
Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+ by immunohistochemistry.
Journal: Virchows Archiv : an international journal of pathology
Published: September 15, 2020
Cystic neutrophilic granulomatous mastitis - a review of 12 consecutive cases.
Journal: Histopathology
Published: April 27, 2020
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP).
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: October 05, 2019
Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
Journal: European radiology
Published: October 02, 2019
Predictors of Outcome in Mammary Adenoid Cystic Carcinoma: A Multi-Institutional Study.
Journal: The American journal of surgical pathology
Published: October 01, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 06, 2019
Last Updated: 09/26/2026